Literature DB >> 19034415

Guidelines for medical management of hyperglycaemia in type 2 diabetes and duality of interest.

D L Eizirik.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19034415     DOI: 10.1007/s00125-008-1225-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

Review 1.  Between two cultures: the expert clinician and the pharmaceutical industry.

Authors:  Edwin A M Gale
Journal:  Clin Med (Lond)       Date:  2003 Nov-Dec       Impact factor: 2.659

Review 2.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

3.  The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003.

Authors:  Paul A Komesaroff; Mark A Bach; Ann Danoff; Melvin M Grumbach; Selna Kaplan; Joan M Lakoski; Dale Leitman; Synthia Mellon; Louis E Underwood; Sarah Leupen
Journal:  Endocrinology       Date:  2004-06       Impact factor: 4.736

4.  Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.

Authors:  P A Komesaroff
Journal:  J Paediatr Child Health       Date:  2005-11       Impact factor: 1.954

5.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

6.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.